All Articles

A new partnership turns existing conference rooms into high-quality TV studios, aiming to boost ROI, culture, and the quality of corporate events.

Facing declining revenue, Goodfood adds restructuring and digital experts to its board. Can this shake-up revive the Canadian meal-kit pioneer?

A new report shows fraud fears in private credit are soaring, fueled by AI and bankruptcies, but data reveals a different story for secured lenders.

EyeMD EMR rebrands as Optivate, launching a unified, AI-driven platform. This move signals a new chapter for eye care practice management.

Axxess's upcoming conference tackles AI's role in home health, unveils a new leadership certification, and honors an industry titan. Here's what it means.

The digital asset giant is delisting from Toronto to streamline costs, a move that reshapes its buyback plan and how Canadian investors trade its stock.

The private equity firm's carve-out of the world's largest coworking franchisor signals a major push to scale flexible workspaces for the hybrid era.

Global advisory firm Consello announces a major UK expansion, investing in The Mentor Hub and hiring top talent to challenge the London advisory market.

Creality's new Sermoon P1 combines standalone processing and multi-mode lasers, offering industrial-grade 3D scanning at a disruptive price point.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

Indian EdTech firm EasyShiksha appoints Deepti Barman to lead strategic alliances, signaling a major push to compete on the global stage.

Ziff Davis nets a massive windfall by selling its Connectivity division, including Ookla and Speedtest, to Accenture in a deal reshaping network intelligence.

With its SMA drug stalled by a factory inspection, Scholar Rock secures major financing and signals a clear path to a transformative market debut in 2026.

Three investment heavyweights—BCI, Norges Bank, and Brookfield—have formed Northview Energy, a new firm set to scale de-risked renewable assets.

With over 100% revenue growth, Ada's success highlights a major industry shift from AI experiments to fully integrated agentic customer experience models.

New research reveals a media blind spot for hearing loss, fueling stigma. A new campaign aims to change the picture and normalize hearing aids for millions.

Modaxo's new brand, Aerivo, emerges from an ADB SAFEGATE acquisition, poised to enhance airport efficiency with its cloud-native Flightivity suite.

A new trial for a cell therapy targeting a rare eye disease offers hope, driven by a patient-advocate's journey and with potential to treat common AMD.

Esperion's $75M+ deal for Corstasis and its novel nasal diuretic, Enbumyst, targets a $4B market and a new era of at-home edema management.

With 74,000 UK mothers losing jobs annually, a new alliance between Momcozy and AllBright uses tech and advocacy to turn the motherhood penalty into power.